EcoDrugPlus

Il2 Inducible T Cell Kinase

Ensembl ID : ENSMAUG00000018699
Gene Symbol: ITK
4 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSMAUG00000010024
Gene Symbol: JAK1
4 Cross references
236 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSMAUG00000008571
Gene Symbol: JAK2
4 Cross references
265 Possible Orthologues:

Janus Kinase 3

Ensembl ID : ENSMAUG00000010255
Gene Symbol: JAK3
1 Cross references
103 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSMAUG00000013726
Gene Symbol: KIT
2 Cross references
264 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSMAUG00000017232
Gene Symbol: KRAS
4 Cross references
201 Possible Orthologues:

Lyl1 Basic Helix-Loop-Helix Family Member

Ensembl ID : ENSMAUG00000008037
Gene Symbol: LYL1
4 Cross references
284 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSMAUG00000004454
Gene Symbol: LYN
3 Cross references
202 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSMAUG00000003952
Gene Symbol: MALT1
4 Cross references
195 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSMAUG00000005670
Gene Symbol: MAPKAPK2
4 Cross references
233 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSMAUG00000010327
Gene Symbol: MKNK2
4 Cross references
220 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSMAUG00000012960
Gene Symbol: MET
4 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).